Please sign in to follow a disease.
New drink promises faster muscle recovery for young athletes
NCT ID NCT07586839
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a drink containing caprylic acid and omega-3 fatty acids can help muscles recover strength after a tough workout. Twenty-eight healthy young men will take the supplement for seven days and do a muscle-damaging exercise. Researchers will measure muscle strength and fatigue before and up to 72 hours after exercise to see if the drink speeds up recovery compared to a control drink.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a drink containing caprylic acid and omega-3 fatty acids
- What this could lead to
- If it works, this could point toward a simple nutritional supplement to speed up muscle recovery after intense exercise.
- What could go wrong
- This is a small, early-stage study in healthy young men only, so results may not apply to others. The effect may be small or no better than a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 28 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 35 years
- Sex
-
Male participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Young (≥18 and ≤35 years) * Male sex * Non-obese (≥18.5 and ≤27.5 kg/m2) * Recreationally active (performing non-competitive exercise at least one time a week for minimally 30 minutes) Exclusion Criteria: * Smoking * Participation in structural exercise with a major eccentric component (e.g. soccer, basketball, trail running, etc…) * Chronic use of any prescribed over the counter pharmaceuticals * Any history of medical or surgical events that may effect the study outcomes * Following a specific diet (e.g. weight loss, ketogenic, vegan) * Taking protein supplements
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Wageningen University and Research
RECRUITINGWageningen, Gelderland, 6708WD, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a protein powder with creatine and fiber boost everyday Well-Being?
- Green tech or hidden stress? bus Drivers' hearts monitored behind the wheel
- Shout it out: can growls and screams raise pain tolerance?
- Scientists probe why brain stimulation works for some and not others
- Tiny doses, big questions: how does the body handle this prodrug?
- First human test of CM583: can this biologic pass the safety check?